AGREEMENT FOR THE TRANSFER OF SPONSORS OBLIGATIONSAgreement • March 22nd, 2005 • Corautus Genetics Inc • Biological products, (no disgnostic substances)
WHEREAS, Corautus Genetics Inc. (hereinafter “CGI”) corporation doing business at 75 Fifth Street, NW, Suite 313, Atlanta, GA 30308 has developed an article pVGI.1(VEGF2) which it wishes to test in clinical trials for myocardial ischemia (MI); and,
Project AddendumCorautus Genetics Inc • March 22nd, 2005 • Biological products, (no disgnostic substances)
THIS PROJECT ADDENDUM (the “Project Addendum”) is made and entered into as of March 7, 2005 (the “Effective Date”) by and between PPD DEVELOPMENT, LP, , a Texas limited partnership, with its principal executive offices located at 3151 South 17th Street, Wilmington, North Carolina 28412 (“PPD”) and CORAUTUS GENETICS, INC., a Delaware corporation, with its principal executive offices located at 75 Fifth Street, NW, Suite 313, Atlanta, GA 30308 (“Sponsor”).
MASTER SERVICES AGREEMENTMaster Services Agreement • March 22nd, 2005 • Corautus Genetics Inc • Biological products, (no disgnostic substances) • North Carolina
THIS MASTER SERVICES AGREEMENT (the “Agreement”) is made and entered into as of March 7, 2005 (the “Effective Date”) by and between PPD DEVELOPMENT, LP, a Texas limited partnership, with its principal executive offices located at 3151 South 17th Street, Wilmington, North Carolina 28412 (“PPD”) and CORAUTUS GENETICS, INC., a Delaware corporation, with its principal executive offices located at 75 Fifth Street, NW, Suite 313, Atlanta, GA 30308 (“Sponsor”)
THIRD AMENDMENT TO THE AMENDED AND RESTATED LICENSE AGREEMENTLicense Agreement • March 22nd, 2005 • Corautus Genetics Inc • Biological products, (no disgnostic substances)
THIS THIRD AMENDMENT TO THE AMENDED AND RESTATED LICENSE AGREEMENT (“Amendment”) made as of the 21st day of March, 2005, by and between VASCULAR GENETICS INC., a Delaware corporation (the “Licensee”) and HUMAN GENOME SCIENCES, INC., a Delaware corporation (“HGS”).
